Authorship rules for medical journals flouted by pharma industry

(Medical Xpress) -- Rather than ensure the proper attribution of authorship, rules set up by leading medical journals to define and credit authorship of published articles are exploited by the pharmaceutical industry in its attempt to conceal and misrepresent industry contributions to the literature.

This is a perspective contained in an article by Alastair Matheson, a medical writer based in the UK and Canada, who argues in this week's that the current International Committee of Medical Journal Editors (ICMJE) authorship guidelines allow for industry to exaggerate the contribution of named academic authors and downplay that of commercial writers who are excluded from authorship but listed as contributors in the small print.

Matheson contends that the ICMJE guidelines should be fundamentally revised and the concept of origination given comparable importance to authorship and contributorship. Pharmaceutical companies and writers who work on industry publications should be listed as byline authors, he says.

In another perspective article, Linda Logdberg of Fernbank Science Center, USA, who worked in the medical communication industry for 11 years, offers her personal view of her work and why she did it, writing that " about have been directed primarily at ''guest'' authors and the pharmaceutical companies that pay them. One voice that is largely missing is that of the ghostwriters themselves who, after all, create the documents that are in the ethical and legal crosshairs. Without them, one could argue, there can be no fraud, because it is they who create the fraudulent product."

add to favorites email to friend print save as pdf

Related Stories

Warning: Ghostwriting may be hazardous to your health

Feb 02, 2010

(PhysOrg.com) -- Of the top 50 medical schools in the United States, as defined by the 2009 U.S. News & World Report’s research ranking, only 13 - or 26 percent - have publicly available policies in place that strictly ...

New strategies to tackle medical ghostwriting are debated

Feb 03, 2009

Better strategies to tackle ghostwriting in the medical literature are the subject of a debate by leading authors in next week's issue of the open-access journal PLoS Medicine. Ghostwriting is scientific misconduct, argues ...

Lost in the middle: author order matters, new paper says

Nov 05, 2007

Rare is the scientific paper today written by a single author. With research being conducted by teams of scientists, most studies now boast a half-dozen or so authors. According to a new study led by a scientist at the Oklahoma ...

Recommended for you

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.